⚕️
Medikal Tanı ve Test Sektörü Hisseleri
Medikal Tanı ve Test Sektörü altında 222 Hisse Senedi
Medikal Tanı ve Test sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$17.5B
Toplam Piyasa Değeri
Medikal Tanı ve Test Sektörü Hisseleri
Sayfa 2/3 (Toplam: 222)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| FTRE | Fortrea Holdings Inc. | $524.90M | $5.80 | 24.46% |
| LAB | Standard BioTools Inc. | $516.56M | $1.36 | 7.94% |
| SIGA | SIGA Technologies, Inc. | $489.37M | $6.85 | 0.00% |
| PACB | Pacific Biosciences of California, Inc. | $486.14M | $1.62 | 12.11% |
| CGEM | Cullinan Oncology, Inc. | $478.61M | $8.11 | 7.85% |
| BFLY | Butterfly Network, Inc. | $467.38M | $1.89 | 0.53% |
| ABSI | Absci Corporation | $463.04M | $3.63 | 3.42% |
| PRTC | PureTech Health plc | $445.67M | $18.55 | 5.68% |
| SENS | Senseonics Holdings, Inc. | $437.49M | $0.58 | 0.38% |
| BVS | Bioventus Inc. | $427.34M | $6.44 | 2.22% |
| MYGN | Myriad Genetics, Inc. | $423.09M | $4.59 | 3.15% |
| AURA | Aura Biosciences, Inc. | $419.77M | $6.77 | 0.00% |
| TECX | Tectonic Therapeutic, Inc. | $414.90M | $22.22 | 1.37% |
| CTKB | Cytek Biosciences, Inc. | $411.64M | $3.25 | 4.84% |
| ARCT | Arcturus Therapeutics Holdings Inc. | $394.06M | $14.53 | 5.37% |
| MLAB | Mesa Laboratories, Inc. | $392.75M | $71.39 | 5.03% |
| EBS | Emergent BioSolutions Inc. | $388.63M | $7.16 | 3.17% |
| CTMX | CytomX Therapeutics, Inc. | $376.53M | $2.39 | 0.42% |
| QSI | Quantum-Si incorporated | $363.06M | $1.80 | 4.65% |
| EHAB | Enhabit, Inc. | $342.31M | $6.76 | 0.60% |
| OM | Outset Medical, Inc. | $335.84M | $18.95 | 8.22% |
| INBX | Inhibrx Biosciences, Inc. | $330.92M | $22.86 | 3.35% |
| TOI | The Oncology Institute, Inc. | $325.37M | $3.54 | 3.81% |
| CATX | Perspective Therapeutics, Inc. | $319.18M | $4.30 | 0.23% |
| CAPR | Capricor Therapeutics, Inc. | $298.01M | $6.52 | 3.99% |
| CERS | Cerus Corporation | $273.36M | $1.43 | 3.62% |
| ANNX | Annexon, Inc. | $260.02M | $2.37 | 4.05% |
| OSUR | OraSure Technologies, Inc. | $258.06M | $3.45 | 6.15% |
| QTRX | Quanterix Corporation | $257.07M | $5.51 | 6.37% |
| MG | Mistras Group, Inc. | $255.96M | $8.17 | 1.36% |
| MASS | 908 Devices Inc. | $253.18M | $7.06 | 1.44% |
| OABI | OmniAb, Inc. | $249.29M | $2.06 | 4.04% |
| LCTX | Lineage Cell Therapeutics, Inc. | $216.94M | $0.95 | 0.60% |
| GALT | Galectin Therapeutics Inc. | $181.01M | $2.86 | 4.38% |
| ALEC | Alector, Inc. | $171.99M | $1.72 | 6.17% |
| BIOA | BioAge Labs, Inc. | $170.65M | $4.76 | 3.48% |
| AGEN | Agenus Inc. | $167.79M | $6.12 | 0.49% |
| NEO | NeoGenomics, Inc. | $165.24M | $6.42 | 3.38% |
| RPID | Rapid Micro Biosystems, Inc. | $161.30M | $3.68 | 8.24% |
| IMRX | Immuneering Corporation | $151.86M | $4.22 | 0.47% |
| DCGO | DocGo Inc. | $144.69M | $1.46 | 2.82% |
| ARAY | Accuray Incorporated | $140.10M | $1.36 | 1.49% |
| LUNG | Pulmonx Corporation | $130.43M | $3.24 | 1.89% |
| SEER | Seer, Inc. | $126.52M | $2.15 | 0.94% |
| SAVA | Cassava Sciences, Inc. | $124.63M | $2.58 | 12.17% |
| GNLX | Genelux Corporation | $124.61M | $3.30 | 5.98% |
| LUCD | Lucid Diagnostics Inc. | $121.18M | $1.12 | 0.90% |
| ATOS | Atossa Therapeutics, Inc. | $111.00M | $0.86 | 1.25% |
| MCRB | Seres Therapeutics, Inc. | $108.19M | $12.39 | 10.54% |
| ANIX | Anixa Biosciences, Inc. | $107.42M | $3.33 | 2.77% |
| ICAD | iCAD, Inc. | $106.31M | $3.87 | 3.75% |
| SERA | Sera Prognostics, Inc. | $105.71M | $2.88 | 1.37% |
| TCRX | TScan Therapeutics, Inc. | $104.69M | $1.85 | 1.09% |
| ABOS | Acumen Pharmaceuticals, Inc. | $101.16M | $1.67 | 7.74% |
| MGNX | MacroGenics, Inc. | $97.16M | $1.54 | 4.76% |
| COYA | Coya Therapeutics, Inc. | $95.17M | $5.69 | 1.56% |
| NAUT | Nautilus Biotechnology, Inc. | $92.72M | $0.73 | 1.10% |
| OCX | OncoCyte Corporation | $91.52M | $3.20 | 17.22% |
| CELU | Celularity Inc. | $89.57M | $3.74 | 18.73% |
| IMMX | Immix Biopharma, Inc. | $79.45M | $2.85 | 4.68% |
| HYPR | Hyperfine, Inc. | $78.62M | $1.01 | 4.24% |
| IPA | ImmunoPrecise Antibodies Ltd. | $77.80M | $1.70 | 2.86% |
| IGMS | IGM Biosciences, Inc. | $76.35M | $1.27 | 0.78% |
| ANRO | Alto Neuroscience, Inc. | $75.80M | $2.80 | 2.56% |
| INO | Inovio Pharmaceuticals, Inc. | $73.89M | $1.45 | 2.11% |
| STRO | Sutro Biopharma, Inc. | $72.38M | $0.86 | 7.13% |
| NOTV | Inotiv, Inc. | $72.14M | $2.10 | 21.39% |
| PYXS | Pyxis Oncology, Inc. | $70.00M | $1.13 | 0.00% |
| CUE | Cue Biopharma, Inc. | $67.74M | $0.90 | 1.81% |
| AKYA | Akoya Biosciences, Inc. | $64.44M | $1.29 | 5.15% |
| INMB | INmune Bio, Inc. | $63.80M | $2.40 | 0.84% |
| IKNA | Ikena Oncology, Inc. | $59.84M | $1.24 | 2.36% |
| RENB | Renovaro Biosciences Inc. | $53.05M | $0.31 | 0.06% |
| BDSX | Biodesix, Inc. | $52.76M | $0.36 | 2.86% |
| PDSB | PDS Biotechnology Corporation | $52.57M | $1.15 | 0.00% |
| SNTI | Senti Biosciences, Inc. | $51.90M | $1.99 | 0.51% |
| MAIA | MAIA Biotechnology, Inc. | $50.61M | $1.67 | 2.34% |
| OVID | Ovid Therapeutics Inc. | $47.57M | $0.67 | 10.49% |
| OPGN | OpGen, Inc. | $47.32M | $4.70 | 0.00% |
| JSPR | Jasper Therapeutics, Inc. | $47.32M | $3.15 | 1.87% |
| LTRN | Lantern Pharma Inc. | $43.46M | $4.03 | 6.33% |
| BEAT | HeartBeam, Inc. | $42.94M | $1.27 | 0.63% |
| CCEL | Cryo-Cell International, Inc. | $42.75M | $5.29 | 12.67% |
| STTK | Shattuck Labs, Inc. | $38.45M | $0.80 | 4.52% |
| RNTX | Rein Therapeutics Inc. | $30.57M | $1.38 | 4.17% |
| FEMY | Femasys Inc. | $28.47M | $0.88 | 0.75% |
| CVM | CEL-SCI Corporation | $28.04M | $5.27 | 21.15% |
| NNVC | NanoViricides, Inc. | $27.32M | $1.70 | 0.59% |
| BOLD | Boundless Bio, Inc. | $26.64M | $1.19 | 3.48% |
| ALXO | ALX Oncology Holdings Inc. | $25.65M | $0.48 | 0.02% |
| FBLG | FibroBiologics, Inc. Common Stock | $25.64M | $0.67 | 0.43% |
| LGVN | Longeveron Inc. | $25.07M | $1.67 | 0.60% |
| ELEV | Elevation Oncology, Inc. | $21.62M | $0.36 | 2.12% |
| PRPO | Precipio, Inc. | $20.87M | $13.80 | 0.72% |
| BCAB | BioAtla, Inc. | $19.94M | $0.34 | 1.58% |
| SYBX | Synlogic, Inc. | $18.71M | $1.60 | 4.45% |
| CTXR | Citius Pharmaceuticals, Inc. | $16.31M | $1.46 | 1.39% |
| PRPH | ProPhase Labs, Inc. | $16.22M | $0.39 | 3.10% |
| AYTU | Aytu BioPharma, Inc. | $15.76M | $2.56 | 7.81% |
| ERNA | Eterna Therapeutics Inc. | $14.80M | $2.01 | 2.55% |